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are also affected by disease-causing protozoans like
Leishmania spp., Trypanosoma cruzi and Trypanosoma
brucei These are the species of trypanosomatids most
associated with human health, being responsible for high
mortality and morbidity[1]. There are still no vaccines and
the actual chemotherapies are far from satisfactory, owing
to the emergence of resistances, serious side effects, and its
limited efficacy. Therefore, it is imperative to continue the
discovery of new drugs to treat these diseases[2].
2. Experimemtal
Naphthalimides and bis-naphthalimides are classes of
compounds bearing aromatic groups that have generated
intense interest by scientists around the world because of
their many reported biological activities. Special attention
has been devoted to the high anticancer activity of
naphthalimides, which is due to their interactions with
DNA by a mechanism of intercalation[3–5]. In addition,
recent studies showed that 1,8-naphthalimide derivatives
also demonstrated other biological activities, such as
antitrypanosomal [6]. In this context, this work proposes to
study the relationship between the structure and the activity
of a set of 1,8-naphtalimide derivatives with 2, 3 or 4
carbons linking the naphthalimide moiety to different
functional groups (amine, imine, guanidine, urea, amide,
and 1,2,3-triazole) against three trypanosomatids:
Leishmania infantum, Trypanosoma brucei and Trypano-
somacruzi. These 1,8-naphtalimide derivatives compounds
had been recently synthesized and include
naphthalimidoalkyl amines 1a, b and its heterocyclic imine
derivatives 2a-l, heterocyclic amine derivatives 3f,g,
guanidine derivatives 4a-c, urea derivatives 5a-l, amide
derivatives 6a-l and triazol derivatives 7d-f[7,8].
Figure 1: Naphthamides compounds 1a,b, 2a-l, 3f,g, 4a-c, 5a-l, 6a-l, 7d-f used in trypanosomatids tests: Leishmania infantum,
Trypanosoma brucei and Trypanosoma cruzi
3. Results and Discussion
All the naphthalimides compounds stock solutions were
prepared in DMSO in a concentration of 10 mm and stored at
-20 °C. Anti T. cruzi (Y strain) activity was performed by
high content screening (adapted from [9]); for T. brucei
(L427 Wild Type) blood stream forms and axenic
amastigote of L. infantum (clone MHOM/MA671TMA-
P263) activity was determined using the resazurin-based
assay[10,11]; intracellular amastigote activity of L. infantum
was performed by luciferase assay (adapted from[12]). The
cellular toxicity of the compounds was evaluated on THP-1
differentiated macrophages using the MTT assay[13]. The
table summarizes the results obtained for the compounds
with relevant anti-parasitic activity at 10 μM concentration.
Overall, our results showthat the best activity was against
T.brucei. The group of naphthalimidoalkyl amines
represented by compound1a and1b show strong inhibition at
concentration 10μM (101±1% inhibition); however
compound 1apresentshigher toxicity with NOAEL (no
observed adverse effect level)> 25μ M in comparison with 1b
NOAEL > 100μM, suggesting that shorter a carbon chain (n
=2) increases the cytotoxicity. The group of heterocyclic
imines compounds 2a-l generally reveals good activity
against T.brucei. Within the imino furan subgroup,
compounds 2b, 2f and 2j, only 2f with 3 carbon atoms chain
shows to be active (101 ± 1% inhibition), and in the subgroup
incorporating imidazole (2d, 2h and 2l) compound 2l, with 4
carbon atoms chain, is the least active. The toxicity for
heterocyclic imines is lower with 3 and 4 carbon chains. The
compound with the best balance activity-toxicity belongs to
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compound 2e, with a three-carbon atom chain and a pyrrole
unit. Heterocyclic amines compounds are also active against
T. brucei, our results showing almost complete inhibition
with compound 3f (99 ± 1% inhibition) and 3g (96 ± 3%
inhibition). However, compound 3g shows lower cytotoxicity
than 3f, with NOAEL > 50μM and > 25μM, respectively.
Guanidine substituted compounds 4a-calso reveals some
anti-T.brucei activity, with a clear tendency for toxicity to
decrease with the increase of the carbon chain length. Within
the urea-substituted compounds 5a-l the most active
compounds against T.brucei, at the concentrations tested, is
5fand 5l both with 4 carbon atom chains. Within this group,
when the carbon chain increases up to four carbon atoms, so
does the activity increase. Also the nature of the terminal
groups in compounds 5a-lis also found to be important for
activity. Comparing the cytotoxicity of the four carbon chain
members in this group (5c, 5f, 5i and 5l), only compound
5cwas found non toxic, suggesting that un-substituted ureas
are less toxic than substituted ureas against THP-1 cell line.
In relation to the triazole group, only compound 7f shows
activity against T. brucei (90 ± 3% inhibition), with toxicity
increasing when the triazole group is linked by a 3 carbon
atoms chain. Regarding T. cruzi, amine 1aand guanidine
4ashows modest anti-parasitic activity (34 ± 9 % inhibition
and 45 ± 9% inhibition, respectively). Urea 5l bearing a 4
carbon atoms chain and a n-butyl group as substituent shows
to be the most active compound of all tested against T. cruzi,
(81 ± 8 % inhibition). However, all compounds that show
some activity against T. cruzi are accompanied by an
increase in cytotoxicity, suggesting a nonspecific mechanism.
Previous studies conducted in our laboratory have shown that
bis-naphthalimidopropyl (BNIP) derivatives compounds
exert significant effects against L.infantum [14]. Surprisingly,
no significant anti-leishmanial activity was found for all the
groups studied; either against L.infantumintracellular and
axenic amastigotes. A hypothesis is that the activity is
dependent on a second naphthilimide group in the molecule.
Overall, the toxicity of the synthesized compounds with a 2
carbon atoms linker presents the higher toxicity. An
exception was observed with the substituted urea-derived
group, where the 4 carbon atoms chain compounds are the
most toxic, with the exception urea 5c. The group of amides
6a-l compounds does not present relevant anti-parasitic
activity (data not shown). In conclusion, naphthalimides
bearing primary alkylamines and un-substituted ureas are the
hits for further research in Trypanosome brucei, in
combination with longer linkers, and O-, N-functionalized
linkers. No interesting results have been found to the other
two trypanosomatids studied.
Table 1: Anti-parasitic activity against Leishmania infantum intracellular amastigotes and axenic amastigotes,
Trypanosoma brucei, Trypanosoma cruzi and cytotoxicity in THP1-derived macrophages for the compounds tested.
Functional groups:
naphthalimidoalkylamines 10μM single dose testing (%activity ± SD) Toxicity
NOAEL
(μM)Compound Radical / Numberof carbons
Leishmania
infantum
intracellular
amastigotes
Leishmania
infantum
axenic
amastigotes
Trypanosoma
brucei
Trypanosoma
cruzi
1a R=NH2 / n=2 23 ± 17 5 ± 5 101 ± 1 34 ± 9 > 25
1b R=NH2 / n=3 N. A. N. A. 101 ± 1 N. A. > 100
Functional group:
Heterocyclic imine
2a X=NH/Y=C/ n=2 N. A. 9 ± 7 101 ± 2 22 ± 13 > 25
2b X=O/ Y=C/ n=2 N. A. 5 ± 0 17 ± 12 N. A. > 25
2c X=S/Y=C/ n=2 N. A. 1 ± 3 8 ± 5 N. A. > 25
2d X=NH/Y=N/ n=2 N. A. 2 ± 1 101 ± 1 25 ± 4 > 25
2e X=NH/Y=C/ n=3 N. A. N. A. 101 ± 1 N. A. > 100
2f X=O/Y=C/ n=3 N. A. 20 ± 21 101 ± 1 N. A. > 50
2g X=S/Y=C/ n=3 N. A. N. A. 101 ± 1 N. A. > 50
2h X=NH/Y=N/n=3 6 ± 13 23 ± 16 99 ± 2 N. A. > 50
2i X=NH/Y=C/ n=4 4 ± 12 1 ± 12 53 ± 5 N. A. > 50
2j X=O/Y=C/ n=4 N. A. 19 ± 4 26 ± 10 N. A. > 50
2k X=S/Y=C/ n=4 N. A. 27 ± 3 94 ± 2 N. A. > 50
2l X=NH/Y=N/ n=4 N. A. 24 ± 12 24 ± 3 N. A. > 100
Functional group:
Heterocyclic amine
3f X=O/Y=C/N=3 N. A. 13 ± 1 99 ± 1 17 ± 15 > 25
3g X=S/ Y=C/N=3 N. A. 9 ± 4 96 ± 3 25 ± 10 > 50
Functional group:
Guanidine
4a R=H/ n=2 N. A. 4 ± 10 100 ± 1 45 ± 9 > 25
4b R=H/ n=3 N. A. 22 ± 8 101 ± 1 N. A. > 50
4c R=H/ n=4 N. A. 10 ± 2 N. A. N. A. > 100
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Functional group:
Ureas
5a R=H/ n=2 N. A. 14 ±1 5 N. A. N. A. > 25
5b R=H/ n=3 N. A. 27 ±1 2 15 ±16 3 ± 8 > 100
5c R=H/ n=4 N. A. 16 ± 5 75 ± 12 N. A. > 100
5d R=4-NO2C6H4/ n=2 N. A. . 11 ± 17 37 ± 8 N. A. > 25
5e R=4-NO2C6H4/ n=3 N. A. N. A. 38 ± 6 26 ± 1 > 25
5f R=4-NO2C6H4/ n=4 N. A. 10 ± 10 94 ± 4 N. A. > 10
5g R=CH2Ph/ n=2 N. A. 30 ± 6 5 ± 4 N. A. > 25
5h R=CH2Ph/ n=3 N. A. 16 ± 0 26 ± 6 21 ± 17 > 10
5i R=CH2Ph/ n=4 N. A. 12 ± 12 74 ± 2 5 ± 8 > 10
5j R=(CH2)3CH3/ n=2 N. A. 14 ± 1 18 ± 10 N. A. > 50
5k R=(CH2)3CH3/ n=3 N. A. 17 ± 14 18 ± 3 20 ± 12 > 25
5l R=(CH2)3CH3/ n=4 N. A. 12 ± 12 96 ± 2 81 ± 8 > 10
Functional group:
1,2,3–Triazole
7e n=2 6 ±16 13 ± 2 12 ± 4 6 ±12 > 100
7d n=3 N. A. 11 ± 4 16 ± 6 N. A. > 50
7f n=4 17 ± 2 N. A. 90 ± 3 22 ± 5 > 100
Results show means activities of at least three independent assays.
NOAEL= No-Observed Adverse Effect Level (MTT assay in PMA-differentiated THP-1 cells);
N. A. = no activity.
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